- About
- Organization
- Organization Overview
- Dean’s Office
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Research
- Education
- Patient Care
- People
- News
- Events
School of Pharmacy tops pharmacy schools in NIH funding for 39th straight year
By Grant Burningham / Wed Feb 27, 2019
The UCSF School of Pharmacy received more research funding from the National Institutes of Health (NIH) than any other pharmacy school in the nation for the 39th year in a row. In total, the School took in $28.9 million in NIH grants in 2018.
As a whole, UC San Francisco was the top public recipient of funding from the NIH in 2018, the 12th year in a row that UCSF claimed the top spot among public institutions. Annual rankings of NIH funding are compiled by the independent Blue Ridge Institute for Medical Research based on the most current government data.
“The School’s research success is clearly evidenced by the NIH funding numbers. But these data don’t tell the whole story,” explained B. Joseph Guglielmo, dean of the UCSF School of Pharmacy. “Behind the numbers is a corps of scientists with a drive to seek and apply new knowledge, a drive that has distinguished this School for more than 39 years.”
Grants from the NIH are used to further the School’s missions of improving patient care and advancing science, funding the investigation of everything from the molecular underpinnings of disease to the optimization of drug regimens for patients.
Top individual grant recipients in the School included Nadav Ahituv, PhD, who is using the money to examine gene regulation in our DNA; William DeGrado, PhD, who is investigating new ways to defeat the flu virus at the molecular level; Brian Shoichet, PhD, who is developing new computational methods for drug discovery; and Deanna Kroetz, PhD, who is working to improve cancer chemotherapy based on genomics.
“Our research successes reveal the deep biology of health and disease, create the evidence for the best use of therapeutics, create engineering solutions to health problems, and guide health policy. Our science continues to fuel breakthroughs that improve the health of people everywhere,” Guglielmo added.
More
UCSF News Center: UCSF Is Top Public Recipient of NIH Funds, Pushing Unbroken Streak
Series
Funding Rankings · Pharmacy
Mon Mar 18, 2024 | School of Pharmacy leads in NIH funding for the 44th straight year |
Mon Feb 20, 2023 | UCSF School of Pharmacy leads in NIH funding for the 43rd straight year |
Tue Feb 15, 2022 | UCSF School of Pharmacy leads in NIH funding for the 42nd straight year |
Thu Feb 18, 2021 | UCSF School of Pharmacy leads in NIH funding for the 41st straight year |
Thu Apr 2, 2020 | UCSF School of Pharmacy leads in NIH funding for the 40th straight year |
Tags
Topics:
Category:
Sites:
School of Pharmacy, Department of Pharmaceutical Chemistry, Department of Bioengineering and Therapeutic Sciences, Department of Clinical Pharmacy, PharmD Degree Program, CCB, PSPG, Bioinformatics, Biophysics, BMI
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.